Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1342086

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1342086

UK Anti-Acne Dermal Patch Market Research Report Forecast to 2030

PUBLISHED:
PAGES: 55 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2950
PDF (Multi User License)
USD 3950
PDF (Enterprise License)
USD 5250

Add to Cart

Market Overview

The growth of the UK anti-acne dermal patch market is attributed to the rising prevalence of acne vulgaris across the UK, increasing demand for instant acne treatment and medications, and increasing awareness about skincare. However, the competition from other acne treatments hampers the market's growth in the forecast period. Nevertheless, it is anticipated that the growing demand for targeted treatment will create lucrative opportunities for the players operating in the UK anti-acne dermal patch market.

The anti-acne dermal patch is a medicated pimple patch containing active ingredients that aid in the elimination of acne-causing bacteria and the reduction of inflammation. These patches improve active ingredient absorption into the skin, reducing pain, bumps, and redness, and are effective in treating inflamed acne, such as papules. Tea tree oil and salicylic acid are common active ingredients in these patches. They may also help to reduce the size of cystic or nodular acne lesions.

The UK anti-acne dermal patch market is emerging due to the increasing demand for instant acne treatment and medications, the rising prevalence of acne vulgaris across the UK, and increasing awareness about skincare. Additionally, the growing demand for targeted treatment will provide growth opportunities for the market in the future. However, the competition from other acne treatments might hamper the market's growth in the forecast period.

Market Overview

Based on acne type, the UK anti-acne dermal patch market has been segmented into inflammatory and non-inflammatory acne. Based on patch type, the UK anti-acne dermal patch market has been segmented into medicated, non-medicated and micro-needle. Medicated further segmented into hydrocolloid based, salicylic acid based, and hyaluronic acid based.

Based on ingredient type, the UK anti-acne dermal patch market has been segmented into chemical based and herbal based. Chemical based further segmented into hydrocolloid based, salicylic acid based, and hyaluronic acid based.

Based on the distribution channel, the UK anti-acne dermal patch market has been segmented into retail stores, pharmacies & drug stores, and e-commerce platform.

Major Players

Rael (US), Avarelle (US), Beauty (UK), Peter Thomas Roth Labs LLC. (US), BEAUTY BAY Ltd. (UK), Dots for Spots (UK), Patchology UK (US), ESK Evidence Skincare Pvt Ltd (Australia), Wishtrend (South Korea), and Balance Active Formula (UK).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING DEMAND FOR INSTANT ACNE TREATMENT AND MEDICATIONS
  • 4.3 RESTRAINTS
    • 4.3.1 COMPETITION FROM OTHER ACNE TREATMENTS
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING DEMAND FOR TARGETED TREATMENT

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS ERROR! BOOKMARK NOT DEFINED.
    • 5.1.1 R&D ERROR! BOOKMARK NOT DEFINED.
    • 5.1.2 MANUFACTURING ERROR! BOOKMARK NOT DEFINED.
    • 5.1.3 DISTRIBUTION & SALES ERROR! BOOKMARK NOT DEFINED.
    • 5.1.4 POST-SALES MONITORING ERROR! BOOKMARK NOT DEFINED.

  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE UK ANTI-ACNE DERMAL PATCH MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON MARKET PLAYERS

6 UK ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE

  • 6.1 OVERVIEW
  • 6.2 INFLAMMATORY ACNE
  • 6.3 NON-INFLAMMATORY ACNE

7 UK ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE

  • 7.1 OVERVIEW
  • 7.2 MEDICATED PATCH
  • 7.3 NON-MEDICATED PATCH
  • 7.4 MICRO-NEEDLE PATCH

8 UK ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE

  • 8.1 OVERVIEW
  • 8.2 CHEMICAL BASED
  • 8.3 HERBAL BASED

9 UK ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 OVERVIEW
  • 9.2 RETAIL STORES
  • 9.3 PHARMACIES & DRUG STORES
  • 9.4 E-COMMERCE PLATFORM

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING

11 COMPANY PROFILES

  • 11.1 WISHTREND
    • 11.1.1 COMPANY OVERVIEWS
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 KEY STRATEGIES
  • 11.2 REVOLUTION BEAUTY
    • 11.2.1 COMPANY OVERVIEWS
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 AVARELLE
    • 11.3.1 COMPANY OVERVIEWS
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 RAEL
    • 11.4.1 COMPANY OVERVIEWS
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 BALANCE ACTIVE FORMULA
    • 11.5.1 COMPANY OVERVIEWS
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGIES

  • 11.6 PETER THOMAS ROTH LABS LLC.
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 SWOT ANALYSIS
    • 11.6.6 KEY STRATEGIES
  • 11.7 DOTS FOR SPOTS
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 PATCHOLOGY UK
    • 11.8.1 COMPANY OVERVIEWS
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 KEY STRATEGIES
  • 11.9 BEAUTY BAY LTD.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 ESK EVIDENCE SKINCARE PVT LTD
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 SWOT ANALYSIS
    • 11.10.6 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 13
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 16
  • TABLE 3 UK ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018-2030 (USD MILLION) 28
  • TABLE 4 UK ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018-2030 (USD MILLION) 30
  • TABLE 5 UK ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018-2030 (USD MILLION) 33
  • TABLE 6 UK ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018-2030 (USD MILLION) 33
  • TABLE 7 UK ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION) 35
  • TABLE 8 MAJOR PLAYERS IN THE UK ANTI-ACNE DERMAL PATCH MARKET 36
  • TABLE 9 WISHTREND: PRODUCTS OFFERED 38
  • TABLE 10 REVOLUTION BEAUTY: PRODUCTS OFFERED 39
  • TABLE 11 AVARELLE: PRODUCTS OFFERED 41
  • TABLE 12 RAEL: PRODUCTS OFFERED 43
  • TABLE 13 BALANCE ACTIVE FORMULA: PRODUCTS OFFERED 45
  • TABLE 14 PETER THOMAS ROTH LABS LLC.: PRODUCTS OFFERED 46
  • TABLE 15 ECOFEMINII LTD.: PRODUCTS OFFERED 48
  • TABLE 16 PATCHOLOGY UK: PRODUCTS OFFERED 49
  • TABLE 17 BEAUTY BAY LTD.: PRODUCTS OFFERED 50
  • TABLE 18 ESK EVIDENCE SKINCARE PVT LTD: PRODUCTS OFFERED 51  

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 11
  • FIGURE 2 UK ANTI-ACNE DERMAL PATCH MARKET 13
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 19
  • FIGURE 4 MARKET DYNAMICS: UK ANTI-ACNE DERMAL PATCH MARKET 21
  • FIGURE 5 DRIVER IMPACT ANALYSIS 22
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS 23
  • FIGURE 7 VALUE CHAIN ANALYSIS: UK ANTI-ACNE DERMAL PATCH MARKET ERROR! BOOKMARK NOT DEFINED.
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: UK ANTI-ACNE DERMAL PATCH MARKET 24
  • FIGURE 9 UK ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2021 & 2030 (USD MILLION) 28
  • FIGURE 10 UK ANTI-ACNE DERMAL PATCH MARKET SHARE, BY ACNE TYPE, 2021 (%) 28
  • FIGURE 11 UK ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2021 & 2030 (USD MILLION) 30
  • FIGURE 12 UK ANTI-ACNE DERMAL PATCH MARKET SHARE, BY PATCH TYPE, 2021 (%) 30
  • FIGURE 13 UK ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2021 & 2030 (USD MILLION) 32
  • FIGURE 14 UK ANTI-ACNE DERMAL PATCH MARKET SHARE, BY INGREDIENT TYPE, 2021 (%) 32
  • FIGURE 15 UK ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2030 (USD MILLION) 35
  • FIGURE 16 UK ANTI-ACNE DERMAL PATCH MARKET SHARE, BY DISTRIBUTION CHANNEL, 2021 (%) 35
  • FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS 37
  • FIGURE 18 REVOLUTION BEAUTY: SWOT ANALYSIS 40
  • FIGURE 19 AVARELLE: SWOT ANALYSIS 42
  • FIGURE 20 RAEL: SWOT ANALYSIS 44
  • FIGURE 21 PETER THOMAS ROTH LABS LLC.: SWOT ANALYSIS 47
  • FIGURE 22 ESK EVIDENCE SKINCARE PVT LTD: SWOT ANALYSIS 52  
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!